The best new products from all of the brands we love in 2018 article Read moreThe news that a UK mother has developed a rare form of breast cancer, following the discovery of an unknown strain of cancer in a cancer-stricken sister, is being heralded as a significant milestone for the NHS and the medical profession.
Theresa May, the Home Secretary, has announced a £4.3bn fund to tackle the NHS’s “disastrous” breast cancer rates, which she says are “incredibly high”.
Theresa told MPs the NHS will spend £10m over the next six months on a “massive campaign to reduce breast cancer deaths”.
The first step, which will also include the introduction of a breast cancer screening test, will be to increase the number of people being screened, she said.
“The NHS has always made the health of women and their families a priority,” Mrs May said.
“But it has also had to cope with the devastating consequences of a changing climate that is not just about climate change but about the rise of new cancers that we know can kill in less than a decade.”
We must not let this happen to our country.
The NHS is the backbone of our economy and is the foundation of our society.
“Her pledge comes as the NHS is facing criticism over the number and type of cancer diagnoses, and a growing number of women who have died in childbirth.
Earlier this year, an estimated 8,000 new cases of the rare form called HER2 were diagnosed in the NHS.
The figures showed that there were 4,907 cases of HER2 across England, while there were 1,917 in Scotland and 1,891 in Wales.
Some of the NHS’ best-known cancer drugs are only available in the UK for about four weeks, but the drug maker AstraZeneca, which also makes Sovaldi, is now testing a new type of breast drug in the US, which could become available for patients who are older than the age of 25.
Earlier in the year, NHS hospitals were forced to halt operations due to fears that the virus that causes HER2 could be passed on through breastfeeding.
In a statement on Monday, NHS Wales said: “We are very grateful for the work of the British Breast Cancer Trust and our team of scientists, nurses and specialists, who have helped us to develop the first-ever new treatment for breast cancer.”
As this is the first time we are testing a novel breast cancer drug, we are confident it will provide great benefits for many women who are still struggling with their cancer.”
But the NHS has warned that the drugs could still pose a threat to the lives of women.
The Department for Health said the drugs were “not suitable” for the elderly and people with compromised immune systems.
The announcement came after a BBC investigation found a growing trend of young women in the world’s largest economy reporting symptoms of breast and ovarian cancer, with some reporting that they had not been told about the risks.
In May, an NHS study showed a woman aged between 18 and 24 with ovarian cancer in the first six months of this year had a 73% chance of developing breast cancer within two years.
According to the BBC, the figure was significantly higher for those aged over 65 and women of all ages.
The news comes amid an increasing number of cases of breast, cervical and vulvar cancer among women in Britain.
Last month, the Health Service Executive said it was working with doctors, nurses, doctors’ assistants and other professionals to increase awareness of the risks of breast disease and other cancers.
A study published in the British Medical Journal found that the risk of developing a breast or cervical cancer in women under 50 was one in four and the risk was one and a half times higher for women aged over 50.
More:The number of cancers diagnosed in England increased by nearly 30% last year, with the number diagnosed in all cancers including breast, uterine and cervical.